| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine. (Chemical Entities of Biological Interest Ontology, CHEBI_6933) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=MIDODRINE |
| Similar Terms | |
| Downloads & Tools |
8 interacting proteins for the MIDODRINE drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| ADRA1B | adrenoceptor alpha 1B | 0.126029 |
| ADRA1A | adrenoceptor alpha 1A | 0.0952014 |
| ADRA1D | adrenoceptor alpha 1D | 0.0618364 |
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.0303509 |
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.0277421 |
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.0226592 |
| CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 0.0216579 |
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.0149357 |